1.
Clin Case Rep
; 7(5): 857-860, 2019 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31110703
RESUMO
All clinicians prescribing amiodarone require knowledge of the challenging diagnosis and management of amiodarone-induced pulmonary toxicity (APT), which is potentially fatal. APT should be considered early in all patients presenting with new respiratory symptoms and concurrent amiodarone therapy. Drug cessation and corticosteroid therapy can be highly effective once recognized.